{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T14:06:04Z","timestamp":1767103564637,"version":"3.48.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["98-01-07-21488"],"award-info":[{"award-number":["98-01-07-21488"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.heliyon.2022.e12641","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T20:12:34Z","timestamp":1671826354000},"page":"e12641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Developing a minimum data set required to create a registry system for patients with vitiligo"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0768-7231","authenticated-orcid":false,"given":"Zahra","family":"Arabkermani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Sheikhtaheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Aryanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peivand","family":"Bastani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafiseh","family":"Esmaeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9446-8453","authenticated-orcid":false,"given":"Azadeh","family":"Bashiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamhossein","family":"Mehralian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Sharifian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9988","key":"10.1016\/j.heliyon.2022.e12641_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12641_bib2","first-page":"214","article-title":"Identification of key genes and pathways involved in vitiligo vulgaris by gene network analysis","volume":"11","author":"Kalavani","year":"2020","journal-title":"Dermatol. Cosmet."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12641_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12641_bib4","first-page":"s115","article-title":"Disorders of hypopigmentation","volume":"18","author":"Dina","year":"2019","journal-title":"J.\u00a0Drugs Dermatol. JDD : J. Drugs Dermatol. JDD"},{"year":"2009","series-title":"Health Care Information Systems: A Practical Approach for Health Care Management","author":"Wager","key":"10.1016\/j.heliyon.2022.e12641_bib5"},{"year":"2014","series-title":"Health Information-E-Book: Management of a Strategic Resource","author":"Abdelhak","key":"10.1016\/j.heliyon.2022.e12641_bib6"},{"year":"2014","series-title":"Registries for evaluating patient outcomes: a User's guide","author":"Gliklich","key":"10.1016\/j.heliyon.2022.e12641_bib7"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12641_bib8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2016.03.020","article-title":"Review of patient registries in dermatology","volume":"75","author":"DiMarco","year":"2016","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.heliyon.2022.e12641_bib9","first-page":"577","article-title":"T\u00a0he national registry for ichthyosis and related","volume":"138","author":"Am","year":"2001","journal-title":"J.\u00a0Pediatr."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e12641_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/09546634.2017.1328549","article-title":"Review of US registries for psoriasis","volume":"28","author":"Amin","year":"2017","journal-title":"J.\u00a0Dermatol. Treat."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12641_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamadermatol.2020.5839","article-title":"A\u00a0global eDelphi exercise to identify core domains and domain items for the development of a global registry of alopecia areata disease severity and treatment safety (GRASS)","volume":"157","author":"Wall","year":"2021","journal-title":"JAMA Dermatol."},{"issue":"Winter","key":"10.1016\/j.heliyon.2022.e12641_bib12","article-title":"The development of a minimum data set for an infertility registry","volume":"15","author":"Abbasi","year":"2018","journal-title":"Persp. Health Inform. Manag."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12641_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0781.2012.00648.x","article-title":"Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy","volume":"28","author":"Hallaji","year":"2012","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12641_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/09546634.2019.1595506","article-title":"Can we consider silymarin as a treatment option for vitiligo? A double-blind controlled randomized clinical trial of phototherapy plus oral Silybum marianum product versus phototherapy alone","volume":"31","author":"Jowkar","year":"2020","journal-title":"J.\u00a0Dermatol. Treat."},{"key":"10.1016\/j.heliyon.2022.e12641_bib15","first-page":"607","article-title":"Sample size determination using Krejcie and Morgan table","volume":"38","author":"Morgan","year":"1970","journal-title":"Kenya Proj. Organ. (KENPRO)"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12641_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-13-117","article-title":"Using the framework method for the analysis of qualitative data in multi-disciplinary health research","volume":"13","author":"Gale","year":"2013","journal-title":"BMC Med. Res. Methodol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12641_bib17","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jisp.2017.01.002","article-title":"The importance of patient registries in skin of color","volume":"18","author":"Hinojosa","year":"2017","journal-title":"J.\u00a0Invest. Dermatol. Symp. Proc."},{"year":"2011","series-title":"Quality of Life and Depression in Patients with Vitiligo","author":"Mahsa","key":"10.1016\/j.heliyon.2022.e12641_bib18"},{"issue":"8","key":"10.1016\/j.heliyon.2022.e12641_bib19","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/jdv.14739","article-title":"The prevalence and odds of depression in patients with vitiligo: a meta-analysis","volume":"32","author":"Wang","year":"2018","journal-title":"J.\u00a0Eur. Acad. Dermatol. Venereol."},{"year":"2021","series-title":"A\u00a0Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)","author":"Bhoyrul","key":"10.1016\/j.heliyon.2022.e12641_bib20"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12641_bib21","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jaad.2012.01.038","article-title":"Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL)","volume":"69","author":"Lilly","year":"2013","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12641_bib22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2005.06456.x","article-title":"Effect of vitiligo on self-reported health-related quality of life","volume":"152","author":"Ongenae","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.heliyon.2022.e12641_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/750342","article-title":"Disease severity indexes and treatment evaluation criteria in vitiligo","volume":"2011","author":"Kawakami","year":"2011","journal-title":"Dermatol. Res. Pract."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022039299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022039299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T14:02:52Z","timestamp":1767103372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022039299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2405844022039299"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12641","relation":{},"ISSN":["2405-8440"],"issn-type":[{"type":"print","value":"2405-8440"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing a minimum data set required to create a registry system for patients with vitiligo","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e12641"}}